Clinical Trials
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma
Bristol Myers Squibb and 2seventy bio, Inc.announced positive topline results from KarMMa-3, a Phase 3, global, randomized, multicenter, open-label study evaluating Abecma (idecabtagene vicleucel) compared...
Clinical Trials
Tallac Reveal They Have Served Their First TAC-001 Patient
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has received...
Clinical Trials
NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab
An early-stage clinical trial assessing an investigational vaccine to stave off Nipah virus infection has been started by the National Institute of Allergy and Infectious...
Clinical Trials
Bharat Biotech Ends Clinical Trial Of Nasal COVID-19 Vaccine
The clinical phase III trials of the COVID-19 nasal vaccination have been finished, according to the Chairman and Managing Director of Bharat Biotech, Dr. Krishna...
Clinical Trials
Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger
New analysis from Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has found that since 2014 the number of women...
Clinical Trials
Calyx Selected by ProTrials as Partner for Improving Clinical Trial Outcomes Data
Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an...
Clinical Trials
Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.